Intelligent Retinal Imaging Systems, Inc.

Intelligent Retinal Imaging Systems (IRIS) focuses on innovative retinal screening solutions to prevent blindness, particularly for diabetic patients, through its advanced cloud-based software platform. Intelligent Retinal Imaging Systems, Inc. , founded in 2011 in Pensacola, US, specializes in retinal screening technology. The company has completed 2 funding deals, with the most recent being In August 2025, Topcon Healthcare Solutions, Inc.

acquired Intelligent Retinal Imaging Systems, Inc. from Allumia Ventures, Ballast Point Ventures, and CoxHealth. Financial terms of the transaction were not disclosed. The firm was established by Sunil Gupta, a notable figure in the healthcare technology sector, and is currently led by CEO Steve Martin.

Intelligent Retinal Imaging Systems (IRIS) provides advanced retinal screening solutions aimed at preventing blindness, specifically for diabetic patients. Its core product, the IRIS retinal screening software, is a cloud-based, camera-agnostic platform that streamlines the capture, enhancement, and diagnosis of diabetic retinopathy. This technology enables healthcare providers, including hospitals, health systems, and federally qualified health centers, to conduct retinal screenings efficiently, addressing care gaps in patient management. The software is compatible with existing electronic medical records (EMRs), offering secure storage and accessibility for board-certified eye specialists, and is utilized by healthcare organizations across the United States in diverse settings such as primary care offices and telemedicine environments.

IRIS generates revenue through a subscription model, offering its software as a service (SaaS) to healthcare organizations. Revenue is derived from partnerships with health risk assessment companies, payors, and healthcare providers utilizing the IRIS platform. Clients typically pay based on user numbers or screening volume, ensuring scalability with operational needs. The company also provides tailored packages that include hardware recommendations, training, and ongoing support, which enhance its value proposition.

Growth in revenue is driven by the increasing adoption of preventative eye care practices and the expansion into new healthcare markets. The company aims to launch new product features and enhancements in the next year, focusing on improving user experience and diagnostic accuracy. Intelligent Retinal Imaging Systems plans to expand its reach into additional US healthcare markets and potentially explore international opportunities by 2025. The acquisition aims to support Topcon Healthcare Solutions, Inc.

’s by the help of Intelligent Retinal Imaging Systems capabilities.